Related Experiment Video
Updated: Jan 15, 2026

WheelCon: A Wheel Control-Based Gaming Platform for Studying Human Sensorimotor Control
Published on: August 15, 2020
Inverse Optimal Control in Conjunction With Inverse Reinforcement Learning for Distributed Parameter Systems
Abstract:
This article focuses on the design of inverse optimal control (IOC) based on inverse reinforcement learning (IRL) for distributed parameter systems (DPSs) with unknown dynamic parameters. First, considering that the optimal policies may not display the expected performance when they are migrated to real-world DPSs due to model bias, the human-behavior learning (HBL) strategy is utilized to transfer the optimal strategy of the reference systems to the real-world DPSs. Furthermore, to avoid performance degradation caused by predefined reward-weight matrices during the optimal control process of the reference systems, the IRL policy iteration algorithm is employed to realize the IOC of the reference systems, and the equivalent reward-weight matrices and optimal control gains of the reference systems are solved. Finally, the effectiveness and superiority of the algorithms are verified in simulation.
Related Concept Videos
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...
Open and closed-loop control systems
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
Distributed Loads: Problem Solving
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
PI Controller: Design
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

